Immune Responses After 2 Versus 3 Doses of HPV Vaccination up to 4½ Years After Vaccination: An Observational Study Among Dutch Routinely Vaccinated Girls.
Donken, Robine Schurink-Van't Klooster, Tessa M Schepp, Rutger M van der Klis, Fiona R M Knol, Mirjam J Meijer, Chris J L M de Melker, Hester E
Donken, Robine
Schurink-Van't Klooster, Tessa M
Schepp, Rutger M
van der Klis, Fiona R M
Knol, Mirjam J
Meijer, Chris J L M
de Melker, Hester E
Citations
Altmetric:
Series / Report no.
Open Access
Type
Article
Language
en
Date of publication
2017-02-01
Year of publication
Research Projects
Organizational Units
Journal Issue
Title
Immune Responses After 2 Versus 3 Doses of HPV Vaccination up to 4½ Years After Vaccination: An Observational Study Among Dutch Routinely Vaccinated Girls.
Translated Title
Published in
J Infect Dis 2017; 215(3):359-67
Abstract
In 2014 the Netherlands switched from 3 to 2 doses for routine vaccination with the prophylactic bivalent human papillomavirus (HPV) vaccine. The current study explored whether antibody responses are noninferior after 2 versus 3 doses in girls.